Literature DB >> 25444536

A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder.

David Louis Pennington1, Christoph Abé2, Steven Laszlo Batki3, Dieter Johannes Meyerhoff4.   

Abstract

Posttraumatic stress disorder (PTSD) patients have low cortical concentrations of γ-aminobutyric acid (GABA) and elevated glutamate (Glu) as measured by proton magnetic resonance spectroscopy ((1)H MRS). Alcohol use disorder (AUD) is highly comorbid with PTSD, but the neurobiological underpinnings are largely unknown. We wanted to determine if PTSD patients with AUD have normalized cortical GABA and Glu levels in addition to metabolite alterations common to AUD. We compared brain metabolite concentrations in 10 PTSD patients with comorbid AUD (PAUD) with concentrtations in 28 PTSD patients without AUD and in 20 trauma-exposed controls (CON) without PTSD symptoms. We measured concentrations of GABA, Glu, N-acetylaspartate (NAA), creatine- (Cr) and choline-containing metabolites (Cho), and myo-Inositol (mI) in three cortical brain regions using (1)H MRS and correlated them with measures of neurocognition, insomnia, PTSD symptoms, and drinking severity. In contrast to PTSD, PAUD exhibited normal GABA and Glu concentrations in the parieto-occipital and temporal cortices, respectively, but lower Glu and trends toward higher GABA levels in the anterior cingulate cortex (ACC). Temporal NAA and Cho as well as mI in the ACC were lower in PAUD than in both PTSD and CON. Within PAUD, more cortical GABA and Glu correlated with better neurocognition. Heavy drinking in PTSD is associated with partially neutralized neurotransmitter imbalance, but also with neuronal injury commonly observed in AUD.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol dependence; Brain metabolite concentrations; GABA; Magnetic resonance spectroscopy; Neuronal injury; PTSD

Mesh:

Substances:

Year:  2014        PMID: 25444536      PMCID: PMC4254450          DOI: 10.1016/j.pscychresns.2014.09.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  44 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

2.  Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART).

Authors:  C W Lejuez; Jennifer P Read; Christopher W Kahler; Jerry B Richards; Susan E Ramsey; Gregory L Stuart; David R Strong; Richard A Brown
Journal:  J Exp Psychol Appl       Date:  2002-06

3.  Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder.

Authors:  N Schuff; T C Neylan; M A Lenoci; A T Du; D S Weiss; C R Marmar; M W Weiner
Journal:  Biol Psychiatry       Date:  2001-12-15       Impact factor: 13.382

4.  Dorsal anterior cingulate cortex: a role in reward-based decision making.

Authors:  George Bush; Brent A Vogt; Jennifer Holmes; Anders M Dale; Douglas Greve; Michael A Jenike; Bruce R Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 5.  Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.

Authors:  Nora D Volkow; Ting-Kai Li
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

Review 6.  Treatment of co-occurring posttraumatic stress disorder and substance use disorders.

Authors:  Erin C Berenz; Scott F Coffey
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

7.  Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites.

Authors:  D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner
Journal:  Alcohol Clin Exp Res       Date:  2004-04       Impact factor: 3.455

Review 8.  The neurocircuitry of impaired insight in drug addiction.

Authors:  Rita Z Goldstein; A D Bud Craig; Antoine Bechara; Hugh Garavan; Anna Rose Childress; Martin P Paulus; Nora D Volkow
Journal:  Trends Cogn Sci       Date:  2009-08-27       Impact factor: 20.229

9.  Neural dysregulation in posttraumatic stress disorder: evidence for disrupted equilibrium between salience and default mode brain networks.

Authors:  Rebecca K Sripada; Anthony P King; Robert C Welsh; Sarah N Garfinkel; Xin Wang; Chandra S Sripada; Israel Liberzon
Journal:  Psychosom Med       Date:  2012-10-31       Impact factor: 4.312

10.  Modeling associations between posttraumatic stress symptoms and substance use.

Authors:  Paige Ouimette; Jennifer P Read; Michael Wade; Vanessa Tirone
Journal:  Addict Behav       Date:  2009-08-19       Impact factor: 3.913

View more
  20 in total

1.  Glutamatergic system abnormalities in posttraumatic stress disorder.

Authors:  Daisuke Nishi; Kenji Hashimoto; Hiroko Noguchi; Kei Hamazaki; Tomohito Hamazaki; Yutaka Matsuoka
Journal:  Psychopharmacology (Berl)       Date:  2015-08-22       Impact factor: 4.530

Review 2.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

Review 3.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

Review 4.  Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.

Authors:  Lynnette A Averill; Prerana Purohit; Christopher L Averill; Markus A Boesl; John H Krystal; Chadi G Abdallah
Journal:  Neurosci Lett       Date:  2016-12-01       Impact factor: 3.046

5.  Regional specificity and clinical correlates of cortical GABA alterations in posttraumatic stress disorder.

Authors:  Isabelle M Rosso; Marisa M Silveri; Elizabeth A Olson; J Eric Jensen; Boyu Ren
Journal:  Neuropsychopharmacology       Date:  2021-10-21       Impact factor: 8.294

Review 6.  Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.

Authors:  Remmelt R Schür; Luc W R Draisma; Jannie P Wijnen; Marco P Boks; Martijn G J C Koevoets; Marian Joëls; Dennis W Klomp; René S Kahn; Christiaan H Vinkers
Journal:  Hum Brain Mapp       Date:  2016-05-04       Impact factor: 5.038

7.  Multimodal and Site-Specific Plasticity of Amygdala Parvalbumin Interneurons after Fear Learning.

Authors:  Elizabeth K Lucas; Anita M Jegarl; Hirofumi Morishita; Roger L Clem
Journal:  Neuron       Date:  2016-07-14       Impact factor: 17.173

8.  N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.

Authors:  Sudie E Back; Kevin Gray; Elizabeth Santa Ana; Jennifer L Jones; Amber M Jarnecke; Jane E Joseph; James Prisciandaro; Therese Killeen; Delisa G Brown; Linda Taimina; Ebele Compean; Robert Malcolm; Julianne C Flanagan; Peter W Kalivas
Journal:  Contemp Clin Trials       Date:  2020-02-19       Impact factor: 2.226

9.  A Systematic Review of the Balloon Analogue Risk Task (BART) in Alcohol Research.

Authors:  Jessica R Canning; Macey R Schallert; Mary E Larimer
Journal:  Alcohol Alcohol       Date:  2022-01-08       Impact factor: 2.826

Review 10.  Oxidative Stress, Inflammation, and Neuroprogression in Chronic PTSD.

Authors:  Mark W Miller; Alex P Lin; Erika J Wolf; Danielle R Miller
Journal:  Harv Rev Psychiatry       Date:  2018 Mar/Apr       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.